Skip to content

The addition of nitric oxide to cardiopulmonary bypass in children - a randomised controlled trial

In cardiac surgery for children on cardiopulmonary bypass, does the addition of nitric oxide to the bypass circuit, compared to not adding nitric oxide, reduce low cardiac output syndrome?

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12615001376538
Enrollment
198
Registered
2015-12-17
Start date
2014-01-03
Completion date
2014-12-23
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

We hypothesised that adding nitric oxide to the cardiopulmonary bypass circuit may reduce the occurrence of low cardiac output syndrome on ICU and improve patient outcomes (such as reducing the need for mechanical ventilation and shorten ICU length of stay)

Interventions

Nitric Oxide was blended with oxygen in the gas administration line to the cpb (cardiopulmonary bypass) circuit, for the duration of cpb which was dependent on procedure (range 30 to 240 mins). Nitric oxide was delivered at 20 parts per million (Ikaria delivery system which measures concentration of nitric oxide delivery electrochemically) Methaemoglobin levels were monitored throughout cpb by the study perfusionist (who was unblinded to whether nitric oxide was to be delivered). Levels were hig

Nitric Oxide was blended with oxygen in the gas administration line to the cpb (cardiopulmonary bypass) circuit, for the duration of cpb which was dependent on procedure (range 30 to 240 mins). Nitric oxide was delivered at 20 parts per million (Ikaria delivery system which measures concentration of nitric oxide delivery electrochemically) Methaemoglobin levels were monitored throughout cpb by the study perfusionist (who was unblinded to whether nitric oxide was to be delivered). Levels were higher in those that received nitric oxide (proving adherence - nitric oxide was indeed being delivered) but never reached clinically important levels.

Sponsors

Intensive Care Unit, Royal Childrens' Hospital, Melbourne
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

any child undergoing cpb for congenital heart disease

Exclusion criteria

emergency cases children requiring inhaled nitric oxide prior to surgery

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 12, 2026